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ABSTRACT 
 
THE RELATIONSHIP BETWEEN ENTERAL NUTRITION FORMULA 
COMPOSITION, FEEDING TUBE PLACEMENT SITE, AND THE START OF 
ENTERAL FEEDINGS ON THE DEVELOPMENT OF VENTILATOR ASSOCIATED 
EVENT IN AN ADULT INTENSIVE CARE UNIT 
by 
Jessica M. Alexander  
 
Background: Ventilator associated pneumonia (VAP) is a major cause of morbidity, 
longer intensive care unit (ICU) stay, increased duration of mechanical ventilation, and 
increased healthcare cost in critically ill patients. Critically ill patients are at increased 
risk for malnutrition, which is associated with impaired immune function, impaired 
ventilator drive and weakened respiratory muscles. Malnutrition has been thought to 
increase the risk of VAP due to bacterial translocation from the gastrointestinal tract to 
the lungs.  Previous research that has evaluated the effect of enteral nutrition on 
malnutrition associated with VAP has been inconsistent in part because of the 
subjectivity of the old definition of VAP. In 2013, the Center for Disease Control and 
Prevention (CDC) developed a new definition for the diagnosis of VAP, which includes 
three tiers of a ventilator associated event (VAE); ventilator associated condition, 
infection-related ventilator-associated complication, or possible or probable VAP). The 
purpose of this study is to retrospectively examine the relationship between enteral 
formula, tube-feeding placement site, time of tube feeding initiation and the incidence of 
VAE using this new CDC definition.
	  	  
Objective:  The aim of the study was to retrospectively examine the relationship between 
enteral formula, tube-feeding placement site, time of tube feeding initiation and the 
incidence of VAE using this new CDC definition. 
Participants/setting:  The medical records of 162 adult patients admitted to one of the 
ICUs (Medical ICU, Surgical ICU, Neurological ICU, Burn ICU) at Grady Memorial 
Hospital (GMH) in Atlanta, GA in 2013 
Main outcome measures: Demographic and baseline medical characteristics including 
the type of enteral formula used (standard, immune-modulating, hydrolyzed, immune-
modulating and hydrolyzed, or mixed), enteral tube feeding placement (gastric or small 
bowel), and timing of enteral nutrition (never fed, fed <48 hours after admission or fed 
>48 hours after admission) were collected.  
Statistical analysis: Demographic and baseline medical characteristics were described 
using frequency statistics and compared by VAE status using the Mann-Whitney U and 
Kruskal-Wallis tests. The relationship between tube placement, enteral formula, timing of 
feeding and the diagnosis of a VAE was evaluated using the Chi-square test. 
Results: In 2013, 81 patients admitted to the ICU at GMH were diagnosed with a VAE.  
The median age of the study population (n=162) was 50 years (range, 19 to 88 years) and 
the median BMI was 27.6 kg/m2 (range, 13.2 to 83.2 kg/m2).  The majority of the 
population was African American (53.1%) and male (64.2%). Most patients were fed 
through a gastric tube (86.4%), were given an immune-modulating enteral formula 
(32.1%) and were fed after 48 hours of admission (44.4%). After subdividing by ICU 
location, 12 of 14 patients (86%) in the Medical ICU who were diagnosed with a VAE 
were either never fed or fed >48 hours after admission vs. 7 of 13 (54%) of patients in the 
	  	  
Medical ICU who were not diagnosed with a VAE (p=0.031).  No other relationships 
between the type of feeding initiation, tube placement, and enteral formula were found by 
VAE status for the population or by ICU location. 
Conclusion:  Adults admitted to the Medical ICU may have a reduced risk of developing 
a VAE if fed within 48 hours of admission.  The type of enteral formula provided and the 
route of administration was not associated with the diagnosis of VAE.  Future prospective 
studies should include all critical care patients to further evaluate the effect of nutrition 
on VAE outcome. 
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CHAPTER I
THE RELATIONSHIPS AMONG ENTERAL NUTRITION FORMULA 
COMPOSITION, FEEDING TUBE PLACEMENT SITE, AND THE START OF 
ENTERAL FEEDINGS ON THE DEVELOPMENT OF A 
VENTILATOR ASSOCIATED EVENT IN AN ADULT INTENSIVE CARE UNIT 
 
Introduction 
Ventilator associated pneumonia (VAP) is a major cause of morbidity, longer 
intensive care unit (ICU) stay, increased duration of mechanical ventilation, and 
increased healthcare cost in critically ill patients.1 Critically ill patients are at increased 
risk for malnutrition because of stress hyper-metabolism.2 Malnutrition is associated with 
impaired immune function, impaired ventilator drive, and weakened respiratory muscles, 
leading to prolonged ventilator dependence and increased infectious morbidity and 
mortality.3,4 Malnutrition is thought to increase the risk for VAP through bacterial 
translocation from the gastrointestinal tract to the lungs.2 It is important to feed critically 
ill patients whenever medically possible to avoid the development of malnutrition. 
However, this does not always happen quickly or efficiently due to the perceived fears of 
complications associated with enteral feeding.  
The effect of enteral nutrition on malnutrition associated with VAP has been 
researched for many years but the literature remains inconsistent. Reasons include 
subjectivity and complexity of the old definition of VAP (used until 2013), lack of 
documentation between facilities, and pressure on physicians to have lower reported
2	  
	  
incidences of VAP. The Centers for Disease Control and Prevention (CDC) recently 
developed a new definition of VAP in an attempt to address some of these issues. The 
new definition for diagnosis uses a combination of objective criteria and recordable data 
that helps in getting close to a standardized VAP definition. VAP prevention as a national 
patient safety goal has been proposed as one of the conditions that is non-reimbursable by 
Medicare and Medicaid1, which intensifies the pressure on physicians to have lower 
incidences of VAP. The subjective nature of the previous definition of VAP caused large 
variation in diagnosis from physician to physician as well as study to study.1 Thus, the 
CDC released the Ventilator Associated Event (VAE) surveillance definition in January 
2013, which is based on an objective, streamlined, and potentially automatable criteria. 
There are three definition tiers with the VAE definition: 1) Ventilator-Associated 
Condition (VAC), 2) Infection- related Ventilator-Associated Complication (IVAC), and 
3) Possible and Probable VAP. These different tiers build upon one another, but all VAEs 
are identified by using a combination of objective criteria: deterioration in respiratory 
status after period of stability or improvement on the ventilator, evidence of infection, or 
inflammation and laboratory evidence of respiratory infection.5 In order to determine the 
validity of the current evidence, objective measures need to be used in future research. 
There is a lack of literature on the relationship between the use of enteral feedings and 
VAE.  The literature evaluating feeding tube placement site and VAP incidence is 
inconsistent and there are no studies examining VAE incidence. Moreover, the 
relationship between the start of enteral feeding and VAP requires reexamination using 
the new CDC definition of VAE. 
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A study was conducted at Grady Memorial Hospital (Grady) in Atlanta, Georgia 
to retrospectively examine the relationship between type of enteral formula, tube-feeding 
placement site, time of tube feeding initiation (within 48 hours vs. after 48 hours) and the 
incidence of VAE. Grady is a Level 1 trauma center with five adult intensive care units. 
Outcome Data Collectors at Grady have been using the new CDC definition of VAE 
since January, 2013.  The research hypotheses of the study were: 
1. Patients who received enteral tube feedings within 48 hours of admission will 
have lower rates of VAE than patients who either received feedings after 48 
hours or did not receive any enteral feedings.     
2. Patients who receive Impact®, an immune-modulating formula, will have a 
lower incidence of VAE than patients receiving other formulas.  
3. Patients who have a nasojejunal tube for enteral feeding will have lower 
incidence of VAE compared to patients with a feeding nasogastric tube.
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CHAPTER II 
Literature Review 
 From 1975 to 1985 the CDC conducted a nationwide study to examine if hospital 
acquired infections could be reduced through control programs. The CDC determined 
that four components of surveillance were needed: 1) feedback of infection control rates 
to hospital staff; 2) enforcement of preventative practices; 3) a supervising infection 
preventionist to collect and analyze surveillance data; and 4) the involvement of a 
physician or microbiologist with specialized training in infection prevention and control.6 
This was the beginning of the CDC recognizing a need for a VAP definition and an 
outline for the different components necessary to survey and diagnose the infection.  In 
1988 the National Nosocomial Infection Survey (NNIS) defined two pneumonia criteria 
for adults that included clinical findings with the results of laboratory tests but did not 
include chest x-rays.7,8 In 2002, the new NNIS pneumonia definitions were implemented, 
which required chest x-ray evidence.7 The new CDC surveillance definition uses a 
combination of objective criteria: deterioration in respiratory status after a period of 
stability or improvement on the ventilator, evidence of infection or inflammation, and 
laboratory evidence of respiratory infection.8  
 
Enteral Feeding Tube Placement 
Four studies have examined the relationship between transpyloric feeding tube 
placement and the incidence of VAP. The study by Acosta-Escribano et al. (2010) 
compared nasogastric (NG) feeding tube to nasojejunal (NJ) feeding tube in patients with
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traumatic brain injuries.9 A total of 104 patients were randomized into either NG (n= 54) 
or NJ (n= 50) tube-feeding placement and were fed the same formula as a continuous 
feeding.  Pneumonia was determined using the clinical pulmonary infection score (CPIS) 
criteria with a score higher than 6 indicating pneumonia. Almost half (n=47) of the 
patients developed VAP, 16 in the NJ group compared with 31 in the NG group (p 
<0.01).  Patients with traumatic brain injuries had decreased incidence of VAP when fed 
through a transpyloric feeding tube than when fed through a nasogastric feeding tube. 
Hsu et al. (2009) compared nasoduodenal (ND) and NG feeding tubes in critically ill 
patients.10 A total of 121 patients were randomized to ND (n=59) and NG (n=62) 
feedings. In this study, VAP diagnosis required the agreement of two third-party 
pulmonologists reviewing radiographs using the CDC criteria. Fifteen patients (24.2%) in 
the NG group compared with 5 (8.5%) patients in the ND group developed VAP (p= 
0.02). Patients in the medical ICU who were fed via an ND tube had lower incidence of 
VAP and better outcomes than those fed with NG tubes.  Davies et al. (2012) also 
compared NJ and NG feedings in mechanically ventilated critically ill adults with 
elevated gastric residual volumes (GRV) within 72 hours of admission to the ICU.11 A 
total of 180 patients were included in the study.  Initially patients were fed through an 
NG tube, then they were randomized to either NJ feedings (n=91) or to remain on NG 
feedings (n=89). An intention to treat analysis was used. Twelve patients randomized to 
the NJ group could not receive the feeding, as the tube did not pass beyond the stomach.  
In addition, eight patients assigned to the NG group were switched to an NJ feeding tube 
due to enteral nutrition intolerance. If the development of VAP was suspected, additional 
data were collected and provided to an adjudication panel.  The diagnosis of VAP was 
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confirmed if at least two of the three adjudicators met the diagnosis of VAP.  Eighteen 
patients in the NJ group and 19 patients in the NG group developed VAP (p = 0.94). 
Switching patients to a NJ feeding tube after they exhibited delayed gastric emptying did 
not significantly decrease the incidence of VAP.    
 White et al. (2009) compared NG and post-pyloric feedings in critically ill 
patients.12 A total of 104 patients were randomized with 54 in the NG group and 50 in the 
post-pyloric group. Four patients originally randomized to NG feeding received a post-
pyloric tube due to increased GRV. Ten patients randomized to post-pyloric feeding 
received a NG tube due to unsuccessful placement of the post-pyloric tube.  VAP was 
diagnosed using a CPIS score greater than 6 and the presence of fever, leukocytosis, 
pulmonary secretions, as well as radiographic imaging.  Under the intent to treat analysis, 
VAP was diagnosed in five patients in the post-pyloric group and eleven in the 
nasogastric group (p=0.18).  Treating patients with early post-pyloric tubes did not 
significantly decrease the incidence of VAP compared to early NG tubes. 
These studies used varying diagnosis of VAP and had high subjectivity toward the 
diagnosis due to the inter-observer variability.1 Radiography as a tool for VAP diagnosis 
has been highly criticized because interpretation is subjective. The new definition 
removes this subjectivity by eliminating the radiographic imaging as part of the 
diagnostic criterion. Furthermore, the results of these studies indicate that the relationship 
between tube-feeding placement site and the incidence of VAP is still unknown.  
Enteral Nutrition Formula and Timing of Implementation 
Very few studies have examined the effect of different enteral adult formulas on 
the incidence of VAP.   Caparros et al. (2001) compared the effect of providing a high-
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protein enteral nutrition formula with supplemental arginine, fiber, and antioxidants to a 
standard high-protein formula on overall nosocomial infection rates in critically ill 
patients.13 The researchers did not specifically analyze data for the presence of VAP. 
Nevertheless, this study did not find a significant relationship between the type of 
formula used and rates of nosocomial infections (p= 0.3). 
In a retrospective study Artinian et al. (2006) examined the effects of nutrition 
timing on VAP incidence in critically ill patients.14 Early feeding was defined as feeding 
within the first 48 hours of mechanical ventilation with patients who were ventilated for 
more than 2 days. VAP diagnosis was defined as new or progressive infiltrate, 
consolidation, cavitation, or pleural effusion of new onset of purulent sputum or change 
in character of sputum, organism isolated from blood culture, isolation of pathogen from 
specimen obtained by tracheal aspirate, bronchial brushing or biopsy, or histopathologic 
diagnosis of pneumonia.14 A total of 2,537 patients had been fed early and 1,512 were 
identified as having received later feedings. After controlling for baseline differences, 
early feeding was associated with a higher risk of VAP development. In the early feeding 
group, 284 patients were diagnosed with VAP compared to 143 in the later feeding group 
(p=0.08). Feeding tube placement was not collected in this patient population and thus 
could not be analyzed. It cannot be ruled out that there may have been a significant 
difference between early and late feeding groups and tube placement. This tube 
placement could have had an effect on VAP.
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CHAPTER III 
 
Methods 
 We conducted a retrospective review of medical records of patients admitted to 
the ICU at Grady Memorial Hospital in Atlanta, GA during 2013. There are five ICUs at 
Grady including two Surgical ICUs (SICUs), a Medical ICU (MICU), a Neurosurgical 
ICU (NICU), and a Burn ICU (BICU). Patients admitted to the SICU were greater than 
18 years old and had life threatening injuries that required immediate surgical 
intervention. Patients admitted to the MICU were greater than 18 years old whose 
admitting diagnoses included organ failure, sepsis, or gastrointestinal bleeding. Patients 
with life threatening neurological issues such as status epilepticus, hemorrhagic or 
ischemic strokes were admitted to the NICU. Admissions to the BICU included both 
pediatric and adult patients who had sustained life-threatening burns to their skin as well 
as smoke inhalation injuries.  
Patients who received mechanical ventilation for more than 48 hours were 
included in the study.  Exclusion criteria included patients below the age of 18 years, 
previous anatomy altering upper gastrointestinal surgery, bowel obstruction, pregnancy, 
presence of a gastrostomy or jejunostomy tube on admission, death within 48 hours, and 
intubation >24 hours after admission.  Patients who developed a VAE were identified 
using a VAE registry maintained by Grady Memorial Hospital infection preventionist. An 
equal number of patients, matched by ICU admission, who were not diagnosed with a 
VAE were randomly selected for comparison.   All patient identifiers (name, birthdate,
9	  
	  
 medical record number, social security number) were removed and an individual patient 
identifier was assigned to protect patient privacy.  The medical records were reviewed for 
demographic and baseline medical characteristics, including, diagnosis of VAE, 
admitting diagnosis, specific enteral feeding tube placement (gastric tube placement or 
small bowel tube placement), the timing of enteral nutrition (before or after 48 hours of 
admission, or never fed enterally), and type of enteral formula used (standard formula or 
immune-modulating formula or hydrolyzed formula or immune-modulating and 
hydrolyzed formula or mixed formula).  
 Standard enteral formulas such as Isosource®, Novasource®, and Jevity® are 
most commonly used to feed patients and contain intact proteins, carbohydrates, long 
chain triglycerides, and vitamins and minerals; some contain fiber. The formulas used in 
this population were Isosource®, Novasource®, Jevity® and Suplena® which is a low 
protein product with lower nutrient content of some vitamins and minerals. Immune 
modulating formulas contain one or more nutrients beyond the standard macro- and 
micronutrients.  These additional nutrients could include arginine, glutamine, omega 3 
fatty acids, antioxidants, gamma linoleic acid, nucleotides, and antioxidants.9 The 
immune-modulating formulas used in this population were Impact® and Oxepa®. 
Hydrolyzed formula is a peptide-based formula that contains 100% enzymatically 
hydrolyzed (elemental) whey protein.10 The hydrolyzed formula used in this population is 
Peptamen® and Peptamen Bariatric®. The immune-modulating, hydrolyzed formula 
contains hydrolyzed casein protein, arginine, glutamine, omega-3 fatty acids and 
nucleotides.11 The immune-modulating, hydrolyzed formula used in this population was
10	  	  
	  
 Impact Peptide®. For the purposes of this study, any patient that received more than one 
category of formula were analyzed as receiving a mixed formula.  
Data were recorded onto a source document and subsequently entered into a 
Microsoft Excel database.  Demographic and baseline characteristics, feeding tube 
placement, and early versus late feedings were described using frequency statistics.  
Variables were compared by VAE status using the Mann- Whitney U test and Kruskal-
Wallis analysis of variance by ranks as the data were not normally distributed even after 
log transformation. The difference in type of tube placement (Gastric vs. Small bowel), 
the type of enteral formula, the initiation of feeding and the incidence of VAE were 
evaluated using a Chi-square test. Data were analyzed as a total population of ICU 
patients and by ICU location as the severity of illness varies among the units.  All 
statistical analyses were conducted using SPSS (version 20.0, SPSS, Inc., Chicago, IL).
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Results 
In 2013, eighty-one patients admitted to the ICU at GMH were diagnosed with a 
VAE.  The comparison group included 81 patients who had not been diagnosed with a 
VAE.  The median age of the study population (n=162) was 50 years (range, 19 to 88 
years) and the median admitting body mass index (BMI) was 27.6 kg/m2 (range, 13.2 to 
83.2 kg/m2) (Table 1). Patients BMI were analyzed because previous studies have shown 
that a higher BMI increases the risk for infection. The majority of the population was 
African American (53.1%) and male (64.2%). The age of patients differed by ICU 
admission status (Table 2).  However, no significant difference in anthropometric status 
was observed by ICU location.  No significant differences in demographic or 
anthropometric characteristics were observed by VAE status (Table 3).
12	  	  
	  
Table 1.  Demographic and anthropometric characteristics of the total population 
 
Characteristics 
 
Total Population 
(n=162) 
Age (years)a 50 (34.75, 63.25) 
Gender (%) 
   Male 
   Female 
 
64.2 
35.8 
Race (%) 
   African American 
   Caucasian 
   Hispanic 
   Asian 
   American Indian 
   Multiracial 
   Unknown 
 
53.1 
34.6 
4.3 
1.9 
0.6 
0.6 
4.9 
Height (m)a 1.727 (1.65, 1.80) 
Weight (kg)a 82 (70, 98.2) 
BMI (kg/m2)a 27.67 (23.9, 32.6) 
aMedian (25%, 75%) 
BMI - Body Mass Index, y – years, m – meters, kg – kilograms
13	  	  
	  
Table 2.  Demographic and anthropometric characteristics of the population by intensive 
care unit (ICU) 
Characteristica Neuro ICU 
(n = 32) 
Burn ICU 
(n = 22) 
Surgical ICU 
(n = 80) 
Medical ICU 
(n = 28) 
P-value 
Age (y) 57 
(45, 66) 
55 
(35, 64) 
43.50 
(26, 57) 
53 
(43, 64) 
0.001 
Height (m) 1.7 
(1.63, 1.77) 
1.75 
(1.7, 1.8) 
1.75 
(1.65, 1.8) 
1.71 
(1.62, 1.77) 
0.145 
Weight (kg) 83.9 
(70.25, 100.52) 
80 
(74.9, 98.1) 
81 
(70, 92.2) 
81.3 
(68.2, 103) 
0.764 
BMI (kg/m2) 30.1 
(23.9, 30) 
27.1 
(24.2, 30.9) 
26.9 
(23.9, 32.1) 
26.8 
(23.3, 36.4) 
0.448 
aMedian (25%, 75%) 
ICU – intensive care unit, BMI – body mass index, y – years, m – meters, kg – kilograms  
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Table 3.  Demographic and anthropometric characteristics by VAE status 
Characteristicsa VAE 
(n = 81) 
NON-VAE 
(n = 81) 
P-value 
Age (y) 49 (32, 64) 51 (35, 63) 0.482 
Height (m) 1.727 (1.65, .80) 1.727 (1.63, 1.80) 0.691 
Weight (kg) 83.9 (70.5, 100) 80 (70, 90) 0.434 
BMI (kg/m2) 27.67 (24.0, 32.8) 27.38 (23.52, 32.17) 0.950 
aMedian (25%, 75%)  
VAE - ventilator associated event; BMI – body mass index, y – years, m - meters, kg – 
kilograms 
The enteral feeding characteristics of the population are shown in Table 4.  Most 
patients were fed through a gastric tube (86.4%), were given an immune-modulating 
enteral formula (32.1%), and were fed after 48 hours of admission (44.4%). The feeding 
tube placement, enteral formula, and time to feeding initiation characteristics by ICU 
status are shown in Table 5. The majority of patients in the BICU, SICU, and MICU who 
received a feeding tube and all NICU patients requiring enteral nutrition support were fed 
via gastric tube.  Most of the patients fed through a small bowel tube were in the SICU. 
Providers in the NICU and MICU prescribed standard enteral formula for the majority of 
their patients.  The SICU providers prescribed an immune-modulating formula more 
frequently while the BICU providers prescribed an immune-modulating, hydrolyzed 
formula more frequently. Dietitians at GMH refer to the American Society of Parenteral 
and Enteral Nutrition/ Society of Critical Care Medicine’s guidelines for the provision
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 and assessment of nutrition support therapy in the adult critical ill patient when making 
recommendations for nutrition support in critically ill patients, which may be the reason 
why an immune-modulating formula was used more frequently.  The majority of patients 
admitted to the NICU and BICU were fed within 48 hours of admission (71.9% and 
36.4%, respectively) while most of the patients in the SICU and MICU were fed after 48 
hours (55% and 50%, respectively). 
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Table 4.  Enteral feeding characteristics of the total ICU population 
Characteristics Total Population 
(n = 162) 
Feeding Tube Placement (%) 
   Gastric 
   Small bowel 
   Unknown 
 
86.4 
5.6 
8.0 
Enteral Formula (%) 
   Standard 
   Immune-modulating 
   Hydrolyzed 
   Immune-modulating, hydrolyzed 
   Mixed formula 
   Unknown 
 
27.8 
32.1 
3.1 
11.7 
8.0 
17.3 
Initiation of Feeding (%) 
   Before 48 hours 
   After 48 hours 
   Never fed enterally 
   Unknown 
 
30.9 
44.4 
22.2 
2.5 
ICU – intensive care unit
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Table 5.  Enteral feeding characteristics of the population by ICU admission status 
 
 
Neuro 
ICU 
(n = 32) 
Burn 
ICU 
(n = 22) 
Surgical 
ICU 
(n=80) 
Medical 
ICU 
(n=28) 
Feeding Tube Placement (%) 
   Gastric 
   Small bowel 
   Unknown 
 
100 
0 
0 
 
95.5 
4.5 
0 
 
78.8 
10 
11.3 
 
85.7 
3.6 
10.7 
Enteral Formula (%) 
   Standard 
   Immune-modulating 
   Hydrolyzed 
   Immune-modulating, hydrolyzed 
   Mixed formula 
   Unknown 
 
78.1 
0 
3.1 
3.1 
9.4 
6.3 
 
0 
22.7 
0 
50 
13.6 
13.6 
 
3.8 
57.5 
1.3 
8.8 
6.3 
22.5 
 
60.7 
3.6 
10.7 
0 
7.1 
17.9 
Initiation of Feeding (%) 
   Before 48 hours 
   After 48 hours 
   Never fed enterally 
   Unknown 
 
71.9 
21.9 
6.3 
0 
 
36.4 
31.8 
31.8 
0 
 
13.8 
55 
27.5 
3.8 
 
28.6 
50 
17.9 
3.6 
ICU – intensive care unit
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The enteral feeding characteristics of the population by VAE status are shown in 
Table 6.  Gastric and small bowel tube placement was similar between patients with and 
without a VAE.  An immune-modulating or hydrolyzed formula was prescribed more 
frequently for patients who were not diagnosed with a VAE vs. those diagnosed.  A 
greater number of non-VAE patients were fed before 48 hours than VAE patients (28 vs. 
22, respectively).  Similarly, more VAE patients were never fed enterally than non-VAE 
patients (21 vs. 15, respectively).  However, these differences were not statistically 
significant.   
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Table 6.  Enteral feeding characteristics of the population by VAE status 
 VAE 
(n = 81) 
Non-VAE 
(n = 81) 
P-value 
Tube Placement (n) 
   Gastric 
   Small bowel  
   No tube/Unknown 
 
72 
4 
5 
 
68 
5 
8 
 
0.685 
Enteral Formula (n) 
   Standard 
   Immune-modulating 
   Hydrolyzed 
   Immune-modulating, hydrolyzed 
   Mixed formula 
   No formula/Unknown 
 
20 
20 
1 
10 
9 
21 
 
25 
32 
4 
9 
4 
7 
 
0.223 
Feeding Initiation (n) 
   Before 48 hours 
   After 48 hours 
   Never fed enterally 
   Unknown  
 
22 
38 
21 
0 
 
28 
34 
15 
4 
 
0.398 
VAE – ventilator associated event 
After subdividing by ICU location, 12 of 14 patients (86%) in the MICU who 
were diagnosed with a VAE were either never fed enterally or fed >48 hours after 
admission vs. 7 of 13 (54%) patients in the MICU who were not diagnosed with a VAE 
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(p=0.031).  No other relationships between the type of feeding initiation, tube placement, 
or enteral formula were found by VAE status for the population or by ICU location 
(Tables 7-10).  
Table 7.  Enteral feeding characteristics by VAE status in patients admitted to the Neuro 
ICU 
 VAE 
(n=16) 
Non-VAE 
(n=16) 
P-value 
Tube Placement (n) 
   Gastric 
   Small bowel  
 
16 
0 
 
16 
0 
 
N/Aa 
Enteral Formula (n) 
   Standard 
   Immune-modulating 
   Hydrolyzed 
   Immune-modulating, hydrolyzed 
   Mixed formula 
   No formula/Unknown 
 
11 
0 
0 
0 
3 
2 
 
14 
0 
1 
1 
0 
0 
 
0.154 
Feeding Initiation (n) 
   Before 48 hours 
   After 48 hours 
   Never fed enterally 
 
10 
4 
2 
 
13 
3 
0 
 
0.282 
aNo statistics are computed because tube placement is a constant 
ICU – intensive care unit
21	  	  
	  
Table 8. Enteral feeding characteristics by VAE status in patients admitted to the Burn 
ICU 
 VAE 
(n=11) 
Non-VAE 
(n=11) 
P-value 
Tube Placement (n) 
   Gastric 
   Small bowel 
   Unknown/no tube  
 
11 
0 
0 
 
10 
0 
1 
 
N/Aa 
Enteral Formula (n) 
   Standard 
   Immune-modulating 
   Hydrolyzed 
   Immune-modulating, hydrolyzed 
   Mixed formula 
   Unknown/No formula 
 
0 
3 
0 
5 
1 
2 
 
0 
2 
0 
6 
2 
1 
 
0.751 
Feeding Initiation (n) 
   Before 48 hours 
   After 48 hours 
  Never fed enterally 
 
4 
5 
2 
 
4 
2 
5 
 
0.276 
aNo statistics are computed because tube placement is a constant 
ICU – intensive care unit 
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Table 9. Enteral feeding characteristics by VAE status in patients admitted to the Surgical 
ICU  
 VAE 
(n=40) 
Non-VAE 
(n=40) 
P-value 
Tube Placement (n) 
   Gastric 
   Small bowel  
  Unknown/No Tube  
 
34 
3 
3 
 
29 
5 
6 
 
0.380 
Enteral Formula (n) 
 Standard 
   Immune-modulating 
   Hydrolyzed 
   Immune-modulating, hydrolyzed 
   Mixed formula 
  Unknown/No tube 
 
2 
17 
0 
5 
4 
12 
 
1 
29 
1 
2 
1 
6 
 
0.134 
Feeding Initiation (n) 
   Before 48 hours 
   After 48 hours 
   Never fed enterally 
   Unknown 
 
6 
22 
12 
0 
 
5 
22 
10 
3 
 
0.925 
ICU – intensive care unit
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Table 10. Enteral feeding characteristics by VAE status in patients admitted to the 
Medical ICU  
 VAE 
(n = 14) 
Non-VAE 
(n = 14) 
P-value 
Tube Placement (n) 
   Gastric 
   Small bowel  
   Unknown 
 
11 
1 
2 
 
13 
0 
1 
 
0.288 
Enteral Formula (n) 
   Standard 
   Immune-modulating 
   Hydrolyzed 
   Immune-modulating, hydrolyzed 
   Mixed formula 
   Unknown/ No formula 
 
7 
0 
1 
0 
1 
5 
 
10 
1 
2 
0 
1 
0 
 
0.846 
Feeding Initiation (n) 
   Before 48 hours 
   After 48 hours 
   Never fed enterally 
   Unknown  
 
2 
7 
5 
0 
 
6 
7 
0 
1 
 
0.031 
ICU – intensive care unit
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CHAPTER V 
 
Discussion and Conclusions 
Patients admitted to an ICU at Grady Memorial Hospital who were mechanically 
ventilated for >48 hours and who received a feeding tube were more likely to be fed an 
immune-modulating formula into their stomach.  Most patients were fed >48 hours after 
admission. We found an association between the lack of initiation of enteral nutrition and 
diagnosis of a VAE in Medical ICU patients but not in any other ICU population.  We 
found no association between feeding tube placement or the type of enteral formula used 
and VAE status in the total population or after subdivision by ICU location.    
Current clinical guidelines recommend that enteral nutrition be started within 24 
to 48 hours of admission.3,12  Artinian et al. (2006) found that early feeding was 
associated with a higher risk of VAP development.  We did not find that early feeding 
was associated with a VAE.  However, Artinian et al. defined early feeding as feeding 
within 48 hours of mechanical ventilation in patients who were ventilated for more than 2 
days and included patients that were not ventilated upon admission.  In our study, patients 
were defined as having been fed early if they were fed within 24 to 48 hours of 
mechanical ventilation but patients had to be mechanically ventilated upon admission. In 
the Artininan et al. study, patients were not excluded if they were not intubated on 
admission.  Therefore, patients may have received food prior to ventilation, which may 
have contributed to their findings.  Moreover, researchers from the study speculate that 
their patient population was less ill suggesting that they may have been fed prior to 
mechanical ventilation and possibly aspirated their food. Our study excluded patients that 
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could feed independently and thus eliminated this possibility.  In contrast, patients in our 
population who were admitted to the MICU and never fed using the gastrointestinal tract 
were more likely to have been diagnosed with a VAE.  
Altintas et al. (2011) conducted a study that examined the effect of enteral vs. 
parenteral nutrition (PN) on outcomes of mechanically ventilated patients.13 The primary 
outcome was the development of VAP. This study was a randomized control trial where 
nutrition support was started within 48 hours on 71 patients. Thirty patients were 
randomized to enteral feedings and the remaining 41 patients received PN. The 
researchers did not find that PN increased the risk of VAP in the medical-surgical ICU. 
While not statistically significant, 26.8% of the patients who received PN developed VAP 
compared to 16.7% of patients who received enteral nutrition.  Our study did find a 
significant association between not receiving enteral nutrition with the diagnosis of a 
VAE in the MICU. This could be because the patients in the category of ‘never fed 
enterally’ included patients that received PN as well as those who received no nutrition. 
This association could also be present because the patients admitted to the MICU were 
more critically ill than the patients admitted to other ICUs. The MICU could have a 
disproportionate number of patients with malnutrition due to the presence of chronic 
disease, which means they could have impaired immune function as well as bacterial 
translocation from the gastrointestinal tract. The patient’s malnutrition is then 
exacerbated once they are admitted with an acute illness and are not fed through the 
gastrointestinal tract.  
 Our results were similar to those of Capparos et al. (2001) with regard to the type 
of enteral formula prescribed.  Approximately 60% of patients in the study received 
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either a standard formula or an immune-modulating formula.  Capparos et al. did not find 
a significant relationship between the type of enteral formula and nosocomial infection, 
which includes VAP. However, the only two formulas used in the study were a standard 
high-protein formula and an immune-modulating formula. Our study also did not find a 
relationship between type of formula and VAE. Therefore, the type of enteral formula 
may not be as important as receiving optimal nutrition. Optimal nutrition is defined as 
meeting energy expenditure as assessed by indirect calorimetry as well as protein intake 
of 1.2 g/kg of preadmission weight for critically ill patients.14 When a patient receives 
optimal nutrition there is a protection and a rebuilding of body protein mass. Inadequate 
nutrition is associated with an increased risk of complications such as infection.14 Given 
that no association between the type of formula prescribed and the development of a 
VAE was found in our study, it is possible that providing adequate calories and protein 
plays a greater role in the relationship.  Nutritional requirements were not determined as a 
part of our study but would be important to evaluate in future research.  
 The findings of this study regarding enteral tube placement and VAE association 
are consistent with the findings of White et al. (2009) and Davies et al. (2012). These 
studies did not find an association between VAP and feeding tube placement. However, 
Acosta-Escribano et al. (2010) and Hsu et al. (2009) found that patients fed into the small 
bowel had a lower incidence rate of VAP. Acosta-Escribano et al. examined feeding tube 
placement only in traumatic brain injury (TBI) patients. While some of the patients in our 
study had experienced TBI, this was not the primary diagnosis in the majority of the 
population. TBI patients are at increased risk for gastroparesis lasting 3-5 days, which 
increases risk for aspiration and which will sometimes necessitate a post-pyloric tube 
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placement.15 Hsu et al. found that patients in the MICU had a lower incidence rate of 
VAP if they were fed into the small bowel. While the current study did not have similar 
findings, it is important to note that the majority of patients (86.4%), regardless of ICU, 
received a gastric tube placement. This did not allow for a true analysis on effectiveness 
of small bowel tube feedings on the incidence of VAE.  
 The primary limitation of our study is that it is retrospective.  We are unable to 
make a determination of cause and effect between VAE and lack of feeding in the 
medical ICU. Furthermore, we are unable to fully evaluate the effect of gastric vs. small 
bowel feeding tube placement and enteral formula type since there were few patients who 
received a small bowel tube or formulas other than standard or immune modulating. After 
subdividing by ICU location, this became more problematic as there were insufficient 
numbers of patients to make the comparison and little diversity in terms of feeding tube 
placement and the type of formula used. Also, some patients’ height, weight and 
calculated BMI were estimated.  Therefore, these results should be interpreted with 
caution. Future research should include analysis of VAE status by BMI category 
(underweight, normal weight, overweight, or obese). Another limitation of the study is 
that patients were excluded if they were intubated after 24 hours of admission. Since we 
did not capture the patients that were intubated later, our results cannot be generalized to 
all ICU patients who are mechanically ventilated. However, by eliminating these patients, 
food consumed orally was not introduced and thus was not a confounding factor in the 
evaluation of the association between the timing of implementation, enteral formula, or 
feeding tube placement and a VAE. Another limitation is that nutrition intake was not 
compared to the patients’ calorie and protein requirements.  Our results may reflect 
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inadequate nutrition vs. the effect of feeding initiation on the development of a VAE.  
 Despite the limitations of our study, adults admitted to the MICU may have a 
reduced risk of developing a VAE if fed within 48 hours of admission. The type of 
enteral formula provided and the route of administration were not associated with the 
diagnosis of VAE.  It is understandable that patients, under certain circumstances (e.g., 
abdominal surgery or being hemodynamically unstable), cannot be fed enterally while 
being mechanically ventilated.  If patients in the MICU cannot be fed, the healthcare 
team should take extra precautions to reduce the risk of the patient having a VAE. These 
precautions include elevating the head of the bed, oral care with chlorhexidine, stress 
ulcer prophylaxis, deep venous thrombosis prophylaxis, daily assessment of sedation and 
spontaneous breathing, improving secretion drainage by body positioning, leakage 
prevention through endotracheal tube modifications, and inhibition of biofilm formation.1 
Increased awareness and preparedness with these patients can help to decrease the risk of 
VAE in the MICU population and improve outcomes.  
Future studies should include a prospective evaluation of all critical care patients 
to further evaluate the effect of nutrition on VAE outcome. In order to further understand 
the relationship between VAE and lack of feeding in the MICU, future randomized 
studies need to be performed in order to determine a cause and effect relationship 
between feeding initiation and VAE. There should be future prospective randomized 
trials including all critical care patients in order to effectively evaluate small bowel vs. 
gastric feeding and the type of enteral formula prescribed. Future research should also 
include studies that match VAE and non-VAE patients by diagnosis and age. 
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